Therefore, decreasing intracellular levels of GSH are associated with many diseases, such as age-related disorders and chronic diseases caused by oxidative stress [3]
The Sustained Release (SR) technology of Metformin ensures gradual drug release, providing prolonged glucose control with reduced gastrointestinal side effects compared to immediate-release formulations
By selectively targeting the brain's appetite control center, this innovative medication helps individuals experience prolonged satiety, ultimately minimizing the inclination to overeat and significantly supporting effective weight management as a result
Because of this, twice-daily use (morning and evening) is a common approach, letting the peptide support the skin around the clock
A 2024 study reported that many people feel a boost in self-confidence after losing significant weight
Diabetes Management: Emerging research suggests it may support diabetes management by improving insulin sensitivity and glucose metabolism (9)